Dr Spyridon Gennatas, Consultant Medical Oncologist

Dr Spyridon Gennatas

Consultant Medical Oncologist

Book online
|

Dr Spyridon Gennatas BSc MBChB MRCP(UK) (Medical Oncology) PhD

Consultant Medical Oncologist

BSc MBChB MRCP(UK) (Medical Oncology) PhD

Dr Spyridon Gennatas

Consultant Medical Oncologist BSc MBChB MRCP(UK) (Medical Oncology) PhD

Book online
|
BSc MBChB MRCP(UK) (Medical Oncology) PhD
HCA-Healthcare-UK

Areas of expertise

  • Lung cancer
  • Brain metastasis
  • Mesothelioma
  • Primary lung tumours
  • Thymus gland cancer
HCA-Healthcare-UK

Address

About Dr Spyridon Gennatas

GMC number: 6143823

Year qualified: 2006

Place of primary qualification: University of Leicester

Dr Spyros Gennatas is a highly skilled and accomplished Consultant Medical Oncologist, specialising in thoracic malignancies such as lung cancer, thymic epithelial tumours, and mesothelioma. He completed his extensive training in medical oncology at the Royal Marsden Hospital in 2019 and holds a PhD from Imperial College London, focusing on genetic alterations leading to thymic epithelial malignancies.

Dr Gennatas has published numerous articles in prestigious, peer-reviewed journals and has presented his research findings at international conferences. His research spans various fields, including molecular genetics, quality of life in cancer patients, Covid-19 and cancer, and medical oncology.

As the Clinical Lead for the Acute Oncology Service at Guy's and St Thomas' hospitals, Dr Gennatas oversees the care of patients with acute complications of cancer treatment, ensuring they receive prompt and effective care. His research interests include developing novel therapeutic agents for thoracic cancers and identifying predictive and prognostic biomarkers to improve patient outcomes.

Dr Gennatas is a highly respected and dedicated oncologist, committed to providing the best possible care for his patients and advancing the field of oncology through his research.

Areas of expertise

  • Biological therapy
  • Brain metastasis
  • Chemotherapy
  • Clinical trials
  • Immunotherapy
  • Lung cancer
  • Mesothelioma
  • Neoadjuvant
  • Primary lung tumours
  • Targeted therapy
  • Thymus gland cancer

Professional memberships

Royal College of Physicians
General Medical Council